Farmacologia

Sibutramine and Cardiovascular Events

Weight loss is fundamental for the prevention of cardiovascular events, so trials to find effective solutions to overweight and obesity are more and more frequently performed. In this trial, sponsored by pharmaceutical industry, over 10,000 subjects with an excess of weight and with known cardiovascular risk factors or with type 2 diabetes and at least another risk factor have been collected.
Approfondisci

 http://mn.medsurfnews.com/contents/en/6207/display/sibutrami...

MedNews